Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Gentamicin Irrigation for Midfacial Fracture Wounds
NCT03483363Phase 4Terminated
- Sponsor
- UTHealth Houston
- Start
- Oct 2018
- Primary completion
- Jan 2022
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 4 trial of gentamicin in surgical site infection (SSI), sponsored by UTHealth Houston. Started Oct 2018; status: terminated.
02
Drugs
gentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03483363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03483363.